Evidence map›Paper›PMID 41050736›Full record

ArticleNew microbes and new infections2025

Global prevalence of

Fukai Bao, Jiaru Yang, Zhenhua Ji, Caijun Zha, Aihua Liu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in New microbes and new infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fukai BaoResearch Center, Baoshan People's Hospital, Baoshan, 678000, Yunnan, China.
Jiaru YangDepartment of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Melbourne, VIC, 3800, Australia.
Zhenhua JiThe Institute of Oncology, Yunnan Cancer Hospital, Kunming Medical University, Kunming, 650100, Yunnan, China.
Caijun ZhaResearch Center, Baoshan People's Hospital, Baoshan, 678000, Yunnan, China.
Aihua LiuYunnan Province Key Laboratory of Children's Major Diseases Research, School of Basic Medicine, Kunming Medical University, Kunming, 650500, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Methods: This meta-analysis was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) statement. We searched studies from the Web of Science, Scopus, Ovid, PubMed, and EBSCO from inception to March 15, 2024. Data were pooled by a random effects model. This study has been registered on PROSPERO (CRDCRD42022380305). Results: We searched 18064 articles and included 34 articles, involving 23851 people. Bb + Ap global coinfection prevalence was 2.9 % (95 % CI 1.8 to 4.3), Bb + Bm was 3.9 % (95 % CI 1.7 to 8.8), Ap + Bm was 0.5 % (95 % CI 0.2 to 1.4), and Bb + Ap + Bm was 2.1 % (95 % CI 0.7 to 5.9). Amongst Bb + Ap group, prevalence of China (1.3 %, 95 %CI 0.9 to 1.7) was lower than that of Europe (3.2 %, 95 % CI 1.9 to 5.2) and USA (2.7 %, 95 % CI 1.0 to 5.3). Conclusions:

Indexed as

Anaplasma phagocytophilumBabesia microtiBorrelia burgdorferiCoinfectionMeta-analysis

Identifiers

PMID41050736
PMCPMC12491743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.